191
Views
7
CrossRef citations to date
0
Altmetric
Theme: Stroke - Review

Paroxysmal atrial fibrillation after ischemic stroke: how should we hunt for it?

&
Pages 485-494 | Published online: 10 Jan 2014

References

  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8), 983–988 (1991).
  • Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36(6), 1115–1119 (2005).
  • Kimura K, Minematsu K, Yamaguchi T; Japan Multicenter Stroke Investigators’ Collaboration (J-MUSIC). Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatr. 76(5), 679–683 (2005).
  • Karatas M, Dilek A, Erkan H, Yavuz N, Sözay S, Akman N. Functional outcome in stroke patients with atrial fibrillation. Arch. Phys. Med. Rehabil. 81(8), 1025–1029 (2000).
  • Sandercock P, Bamford J, Dennis M et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). BMJ 305(6867), 1460–1465 (1992).
  • Saxena R, Koudstaal P. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst. Rev. 4, CD000187 (2004).
  • Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J. Interv. Card. Electrophysiol. 4(2), 369–382 (2000).
  • Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 4(6), 816–861 (2007).
  • McNamara RL, Brass LM, Drozda JP Jr et al.; American College of Cardiology; American Heart Association. ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Commitee to Develop Data Standards on Atrial Fibrillation). J. Am. Coll. Cardiol. 44(2), 475–495 (2004).
  • Fuster V, Rydén LE, Asinger RW et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 104(17), 2118–2150 (2001).
  • Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J. Stroke Cerebrovasc. Dis. 21(2), 89–93 (2012).
  • Tayal AH, Tian M, Kelly KM et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology 71(21), 1696–1701 (2008).
  • Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J. Stroke Cerebrovasc. Dis. 18(3), 185–189 (2009).
  • Patel MR, Mahaffey KW, Garg J et al.; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365(10), 883–891 (2011).
  • Prasad V, Kaplan RM, Passman RS. New frontiers for stroke prevention in atrial fibrillation. Cerebrovasc. Dis. 33(3), 199–208 (2012).
  • Connolly SJ, Ezekowitz MD, Yusuf S et al.; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361(12), 1139–1151 (2009).
  • Adams HP Jr, del Zoppo G, Alberts MJ et al.; American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38(5), 1655–1711 (2007).
  • Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25(5), 457–507 (2008).
  • Scottish Intercollegiate Guidelines Network (SIGN). Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention. A national clinical guideline. SIGN Guideline No. 108 (2008).
  • National Institute for Clinical Excellence UK (NICE). Stroke: Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). NICE Clinical Guideline No. 68 (2008).
  • Mant J, Wade D, Winner S. Health care needs assessment: stroke. In: Health Care Needs Assessement: The Epidemiologically Based Assessment Reviews. Stevens A, Raftery J, Mant J, Simpson S (Eds). Radcliffe Medical Press, Oxford, UK, 141–244 (2004).
  • Camm AJ, Lip GY, De Caterina R et al.; ESC Committee for Practice Guidelines (CPG); Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur. Heart J. 33(21), 2719–2747 (2012).
  • Barsky AJ. Palpitations, arrhythmias, and awareness of cardiac activity. Ann. Intern. Med. 134(9 Pt 2), 832–837 (2001).
  • Mehall JR, Kohut RM Jr, Schneeberger EW, Merrill WH, Wolf RK. Absence of correlation between symptoms and rhythm in ‘symptomatic’ atrial fibrillation. Ann. Thorac. Surg. 83(6), 2118–2121 (2007).
  • Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke. Lancet 343(8899), 687 (1994).
  • Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am. J. Cardiol. 74(3), 236–241 (1994).
  • Meschia JF, Merrill P, Soliman EZ et al. Racial disparities in awareness and treatment of atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke 41(4), 581–587 (2010).
  • Soliman EZ, Howard G, Meschia JF et al. Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke 42(10), 2950–2953 (2011).
  • Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J. R. Coll. Physicians Edinb. 42(Suppl. 18), 5–22 (2012).
  • Atrial fibrillation: national clinical guideline for management in primary and secondary care. National Collaborating Centre for Chronic Conditions. NICE, UK (NICE). (2006).
  • Sposato LA, Klein FR, Jáuregui A et al. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring. J. Stroke Cerebrovasc. Dis. 21(3), 210–216 (2012).
  • Rem JA, Hachinski VC, Boughner DR, Barnett HJ. Value of cardiac monitoring and echocardiography in TIA and stroke patients. Stroke 16(6), 950–956 (1985).
  • Francis DA, Heron JR, Clarke M. Ambulatory electrocardiographic monitoring in patients with transient focal cerebral ischaemia. J. Neurol. Neurosurg. Psychiatr. 47(3), 256–259 (1984).
  • Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute Stroke Stroke 39(2), 480–482 (2008).
  • Gaillard N, Deltour S, Vilotijevic B et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology 74(21), 1666–1670 (2010).
  • Organised in-patient (stroke unit) care for Stroke. Cochrane Database Syst Rev. 4, CD000197 (2007).
  • Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J. Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 34(1), 101–104 (2003).
  • Kallmünzer B, Breuer L, Hering C et al. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic Stroke. Stroke 43(4), 994–999 (2012).
  • Rizos T, Güntner J, Jenetzky E et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43(10), 2689–2694 (2012).
  • Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 124(4), 477–486 (2011).
  • Zimetbaum P, Goldman A. Ambulatory arrhythmia monitoring: choosing the right device. Circulation 122(16), 1629–1636 (2010).
  • Gumbinger C, Krumsdorf U, Veltkamp R, Hacke W, Ringleb P. Continuous monitoring versus HOLTER ECG for detection of atrial fibrillation in patients with stroke. Eur. J. Neurol. 19(2), 253–257 (2012).
  • Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism. Intern. Med. J. 34(6), 305–309 (2004).
  • Stahrenberg R, Weber-Krüger M, Seegers J et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 41(12), 2884–2888 (2010).
  • Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke 41(7), 1514–1520 (2010).
  • Wachter R, Stahrenberg R, Gröschel K. Letter by Wachter et al regarding article ‘Cost–effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke’. Stroke 42(3), e36; author reply e37 (2011).
  • Barthélémy JC, Féasson-Gérard S, Garnier P et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann. Noninvasive Electrocardiol. 8(3), 194–199 (2003).
  • Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke 35(7), 1647–1651 (2004).
  • Wallmann D, Tüller D, Wustmann K et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke 38(8), 2292–2294 (2007).
  • Vasamreddy CR, Dalal D, Dong J et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol. 17(2), 134–139 (2006).
  • Klemm HU, Ventura R, Rostock T et al. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 17(2), 146–150 (2006).
  • Dion F, Saudeau D, Bonnaud I et al. Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J. Interv. Card. Electrophysiol. 28(2), 101–107 (2010).
  • Glotzer TV, Hellkamp AS, Zimmerman J et al.; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107(12), 1614–1619 (2003).
  • Ziegler PD, Glotzer TV, Daoud EG et al. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke 41(2), 256–260 (2010).
  • Ali M, Bath PM, Curram J et al. The Virtual International Stroke Trials Archive. Stroke 38(6), 1905–1910 (2007).
  • Ali M, Bath P, Brady M et al.; VISTA Steering Committees. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int. J. Stroke 7(2), 133–138 (2012).
  • Kamel H, Lees KR, Lyden PD et al.; Virtual International Stroke Trials Archive Investigators. Delayed detection of atrial fibrillation after ischemic stroke. J. Stroke Cerebrovasc. Dis. 18(6), 453–457 (2009).
  • Okada Y, Shibazaki K, Kimura K, Iguchi Y, Miki T. Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack. Eur. J. Neurol. 17(2), 326–331 (2010).
  • Montaner J, Perea-Gainza M, Delgado P et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39(8), 2280–2287 (2008).
  • Sinha AM, Diener HC, Morillo CA et al. Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am. Heart J. 160(1), 36–41.e1 (2010).
  • Lewis M, Parker D, Weston C, Bowes M. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br. J. Gen. Pract. 61(582), 38–39 (2011).
  • Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am. J. Hypertens. 22(8), 848–852 (2009).
  • Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J. Hum. Hypertens. 23(10), 654–658 (2009).
  • Lees KR, Bluhmki E, von Kummer R et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375(9727), 1695–1703 (2010).
  • Cucchiara B, Kasner SE, Tanne D et al.; SAINT Investigators. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials. Stroke 40(9), 3067–3072 (2009).
  • Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke 41(9), 1990–1995 (2010).
  • Schuchert A, Behrens G, Meinertz T. Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin. Electrophysiol. 22(7), 1082–1084 (1999).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.